Progress and deadlock in German health reforms
This article was originally published in Clinica
Executive Summary
The German coalition government has made progress in one area of the health reforms while talks have broken down in another. The government pushed through its emergency cost-cutting proposals in the Bundestag (lower house) late last month. It is expected that the bill will be passed in September. The government claims that the proposed cost-cutting measures will result in savings of some DM 7,000 million ($4,700 million), which will enable it to cut the average healthcare insurance contribution rate by 0.4%.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.